CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim
September 12, 2024 08:00 ET | CVRx, Inc.
New data published in JACC: Heart Failure demonstrate durable benefits in MLWHF and EQ-5D quality of life measures in heart failure patients with reduced ejection fraction MINNEAPOLIS, Sept. 12,...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx Announces Appointment of Two New Board Members
September 03, 2024 08:30 ET | CVRx, Inc.
MINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced the appointments of Kevin Ballinger and Mitch Hill to...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx Announces Increased Inpatient Payment for Barostim Procedure
August 02, 2024 08:00 ET | CVRx, Inc.
MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that Centers for Medicare and Medicaid Services (CMS)...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference
July 31, 2024 16:27 ET | CVRx, Inc.
MINNEAPOLIS, July 31, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the Canaccord...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx Reports Second Quarter 2024 Financial and Operating Results
July 29, 2024 16:05 ET | CVRx, Inc.
MINNEAPOLIS, July 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024
July 15, 2024 16:30 ET | CVRx, Inc.
MINNEAPOLIS, July 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx Announces Appointment of Robert Allen John as Chief Revenue Officer
June 25, 2024 06:50 ET | CVRx, Inc.
MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced the appointment of Robert John as Chief Revenue Officer...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx to Present at the William Blair 44th Annual Growth Stock Conference
May 22, 2024 08:30 ET | CVRx, Inc.
MINNEAPOLIS, May 22, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the William...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx Announces Key Senior Leadership Team Hires
May 16, 2024 07:30 ET | CVRx, Inc.
Dr. Philip B. Adamson will join as Chief Medical OfficerBonnie Handke will join as Senior Vice President of Patient Access, Reimbursement, and Healthcare EconomicsJennifer E. Englund joins as Senior...
CVRX_Outsmart the heart_Logo_RGB Blue.png
CVRx Reports First Quarter 2024 Financial and Operating Results
April 30, 2024 16:05 ET | CVRx, Inc.
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...